Centene Corp (CNC)

Currency in USD
65.58
-1.87(-2.77%)
Closed·
65.35-0.23(-0.35%)
·
CNC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
63.9168.09
52 wk Range
31.6378.08
Key Statistics
Prev. Close
65.58
Open
67.64
Day's Range
63.91-68.09
52 wk Range
31.63-78.08
Volume
5.54M
Average Vol. (3m)
4.98M
1-Year Change
88.286%
Book Value / Share
44.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
76.00
Upside
+15.89%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Centene Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

8 Buy
12 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 76.00
(+15.89% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Bernstein SocGen Group
Buy90.00+37.24%79.00MaintainNov 17, 2026
Truist Securities
Buy82.00+25.04%80.00MaintainNov 02, 2026
Wells Fargo
Hold75.00+14.36%69.00MaintainOct 30, 2026
JPMorgan
Hold75.00+14.36%67.00MaintainOct 29, 2026
Jefferies
Hold69.00+5.22%59.00MaintainOct 29, 2026

Centene Corp SWOT Analysis


Margin Pressures
Discover how Medicare Advantage break-even efforts face PDP-related headwinds creating negative $0.74 earnings impact, while favorable underwriting cycles through 2028 could drive upside
Analyst Valuations
Price targets range from $41 to potential $120 valuations, with fiscal 2026 EPS estimates at $3.45-$3.50 and Medical Loss Ratio projections at 91.6 percent
Medicaid Headwinds
The company navigates a projected 6 percent Medicaid enrollment decline for 2026, tracking mid-4 percent attrition rates amid ongoing state eligibility redeterminations
ACA Growth Engine
Centene's strategic positioning in the Individual ACA marketplace offers substantial expansion potential, with analysts projecting valuations near $120 based on fiscal 2028 earnings of $9.00
Read full SWOT analysis

Centene Corp Earnings Call Summary for Q3/2026

  • Centene Q3 adjusted EPS hit $0.58, crushing $0.10 estimate; revenue of $50.65B topped forecasts by 7.5%, driving shares up 2.49% premarket.
  • Full-year 2026 adjusted EPS guidance raised to above $5.20 from above $4.80, signaling sustained operational momentum across business lines.
  • Medicare Advantage on track for break-even in 2026, one year ahead of plan; Marketplace margins now targeting top of 4.5%-5% range.
  • Total debt cut to $15.0B from $18.5B at end-2024; operating cash flow reached $4.3B year-to-date despite quarterly timing headwinds.
  • Management expects 2027 EPS growth versus 2026, with Medicare improving beyond break-even and SG&A declining from optimization efforts.
Last Updated: 10/27/2026, 09:43 AM
Read Full Transcript

Earnings

Latest Release
Oct 27, 2026
EPS / Forecast
0.58 / 0.10
Revenue / Forecast
50.65B / 47.11B
EPS Revisions
Last 90 days

CNC Income Statement

Compare CNC to Peers and Sector

Metrics to compare
CNC
Peers
Sector
Relationship
P/E Ratio
22.2x28.2x−0.2x
PEG Ratio
0.180.210.00
Price / Book
1.5x4.4x2.6x
Price / LTM Sales
0.2x0.4x2.7x
Upside (Analyst Target)
15.9%40.4%72.2%
Fair Value Upside
Unlock25.4%12.4%Unlock

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
240.52M48.58%16.22B
Other Institutional Investors
265.44M51.42%17.90B
Public Companies & Retail Investors
0.000.00%0.00
Total
505.97M100.00%34.13B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.37%41,446,0462,795,536
Vanguard Capital Management, LLC6.90%34,139,1602,302,686

People Also Watch

380.00
HUM
-1.50%
99.94
ACLS
-1.03%
15.33
KD
-1.92%
489.19
AMD
-7.72%

FAQ

What Is the Centene (CNC) Stock Price Today?

The Centene stock price today is 65.58 USD.

What Stock Exchange Does Centene Trade On?

Centene is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Centene?

The stock symbol for Centene is "CNC."

What Is the Centene Market Cap?

As of today, Centene market cap is 32.47B USD.

What Is Centene's Earnings Per Share (TTM)?

The Centene EPS (TTM) is 2.96.

When Is the Next Centene Earnings Date?

Centene will release its next earnings report on Feb 09, 2027.

From a Technical Analysis Perspective, Is CNC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Centene Stock Split?

Centene has split 4 times.

How Many Employees Does Centene Have?

Centene has 61100 employees.

What is the current trading status of Centene (CNC)?

As of Nov 20, 2026, Centene (CNC) is trading at a price of 65.58 USD, with a previous close of 65.58 USD. The stock has fluctuated within a day range of 63.91 USD to 68.09 USD, while its 52-week range spans from 31.63 USD to 78.08 USD.

What Is Centene (CNC) Price Target According to Analysts?

The average 12-month price target for Centene is 76.00 USD, with a high estimate of 90 USD and a low estimate of 62 USD. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +15.89% Upside potential.

What Is the CNC Premarket Price?

CNC's last pre-market stock price is 67.65 USD. The pre-market share volume is 4,170.00, and the stock has decreased by 0.20, or 0.30%.

What Is the CNC After Hours Price?

CNC's last after hours stock price is 65.35 USD, the stock has decreased by -0.23, or -0.35%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.